Followers | 43 |
Posts | 4255 |
Boards Moderated | 0 |
Alias Born | 07/14/2010 |
Monday, October 02, 2023 12:39:38 PM
Recent GPCR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:56:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:36 PM
- Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/08/2024 09:19:19 PM
- Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/08/2024 09:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 02:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 01:43:20 PM
- Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights • GlobeNewswire Inc. • 03/08/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 01:28:47 PM
- Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study • GlobeNewswire Inc. • 12/18/2023 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/30/2023 05:15:14 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2023 10:25:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:55:37 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 11/17/2023 09:51:18 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 11/16/2023 10:13:32 PM
- Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights • GlobeNewswire Inc. • 11/14/2023 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 11:50:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 11:38:34 AM
- Structure Therapeutics Announces $300 Million Private Placement Equity Financing • GlobeNewswire Inc. • 09/29/2023 11:32:00 AM
- Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update • GlobeNewswire Inc. • 09/29/2023 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:41:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:19:34 PM
- Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights • GlobeNewswire Inc. • 08/10/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:30:21 PM
- Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors • GlobeNewswire Inc. • 08/03/2023 09:32:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM